vinorelbinedocetaxelTHIOgemcitabinecemiplimabTHIO-104NSCLCplatinum-based chemotherapy
…by cemiplimab 350 mg IV on Day 5, or single-agent chemotherapy (vinorelbine, gemcitabine, or docetaxel). The primary endpoint is overall su…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 541–600 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
N-Acetyl Cysteine7PPIs7Streptozotocin7fondaparinux7high-dose corticosteroids7hydroxyurea7naltrexone7tyrosine kinase inhibitors7vaccines7SGLT-2i6Glipizide6BLV6Varenicline6Camrelizumab6Cancer Drugs6Benzene6Doxy-PEP6SGLT-2is6Aprepitant6DEX6Dostarlimab6T-DXd6Azacitidine6Esketamine6NAC6Fidaxomicin6ITM6Minocycline6N-acetylcysteine6pMDIs6NBCA6Clofazimine6Filgotinib6Ravulizumab6Atomoxetine6Methylphenidate6amoxicillin-clavulanate6Acetylcysteine6Triamcinolone6anti-PD16Nitrous oxide6Octreotide6injectate6IL-1β6Lenalidomide6OAC6Venetoclax6antihypertensive drugs6n-BCA6Anti-TNF6Golimumab6Placebo6aripiprazole6b/tsDMARDs6Lansoprazole6MDPV6Mitomycin C6Nalbuphine6PCSK9 inhibitors6Sodium-Glucose Co-Transporter 2 Inhibitors6
Articles mentioning drugs
10,506 articles · page 122 of 876IMA203PRAMEPRAME-derivedPRAME-directedadvanced melanomaImmatics US, Inc.
…ing success and improve final product characteristics. Notably, IMA203 manufacturing achieved a 95% success rate at the RP2D (1-10x10 …
PH-762INTASYLMerkel cell carcinomacutaneous squamous cell carcinomamelanomaAdvarra Institutional Review Boardtumor
… 3.0 cm in longest dimension. Escalating dose concentrations of PH-762 (from 1.14 mg/mL through 22.00 mg/mL) are tested serially in co…
STAR0602mSTAR1302cisplatinhead and neck squamous cell carcinoma (HNSCC)NIH Intramural Animal Care and Use Committeecarcinogen-associated HNSCCC57BL/6 mice
…sions These findings provide a rationale for the combination of STAR0602 and SOC therapy in the clinical setting for patients with recur…
ABT-863solid tumorsCRObreastlung cancersIACUC
…usted CD8+ T cells and enhanced anti-tumor immunity.Conclusions ABT-863 is a first-in-class CCR8 inverse agonist antibody that promotes…
nivolumabIMANssolid tumorsLIfT BioScienceshead and neck squamous cell carcinoma
…d and neck squamous cell carcinoma (HNSCC), IMANs combined with nivolumab induced greater tumor cytotoxicity than CPI alone. Notably, IMA…
Ciurea SOcam161533NKTR-255neuroblastomaAMLacute myelogenous leukemia
…ly relapsed and refractory AML. Am J Hematol 2024:99(5):890-899.Ciurea SO, Schafer JR, Bassett R, Denman CJ, Cao K, Willis D, Rondon G, C…
NKTR-255HSV C021neuroblastomaGlioblastomaGBM
…expressing human IL-21(HSV C021) in combination with ROR1.CAR.5 NKTR-255 is an investigational IL-15Rα-dependent, polymer-conjugated IL-…
IL-15ReovirusPBSprostate cancerUniversity of SurreyUK Home Officeprostate tumoursAkoya BiosciencesThe Prostate Project
…nti-tumour immunity and the benefit of combination therapy with IL-15 to enhance ICI responsiveness and anti-tumour activity.Methods …
KAN-001MD Anderson Cancer Centernon-small cell lung cancerNSCLCCRCHUManti-PD-1 therapyCanadian CouncilPD-1 therapy
… secondary assessments of engraftment and preliminary efficacy. KAN-001 will be administered orally in an encapsulated frozen liquid fo…
FASNianti-PD-1glioblastomaTCGA
…lator of anti-tumor immunity. Critically, the combination of RT+FASNi+anti-PD-1 induces durable tumor rejection and immunological mem…
STK-012pembrolizumabmSTK-012cancerNCT05098132Non-small cell lung cancerNSCLC
…mab and chemotherapy. These findings highlight the potential of STK-012 to overcome key limitations of the next wave immunotherapies by…